FDA hones activities amid shutdown, but impact on drugmakers appears limited so far

0
25
FDA commissioner highlights efforts to improve expanded access program


A regulatory consultant said his clients had not experienced any significant disruption, and the agency has been responsive to inquiries.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here